However, cisplatin treatment significantly increased the number of IFN-γ+/CD8+ T cells by twofold in the C57BL/7 mice with miR-424(322)-overexpressing tumours, which suggests that miR-424(322) enhanced the efficacy of chemotherapy by CTL activation. Here, CD8A is linked to neoplasm.